Acknowledgements
The author thanks his colleagues Yongjun Guan, Bob Gallo, Tony DeVico and Roberta Kamin-Lewis for discussions leading to the ideas in this editorial.
Financial & competing interests disclosure
George K Lewis is a shareholder in Profectus Biosciences (MD, USA). He is also a co-inventor on pending patents covering methods to isolate monoclonal antibodies cited in this report. Research in the author’s laboratory is supported by grants from the NIH (R01AI087181 and R01AI084830) and the Bill and Melinda Gates Foundation. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.